Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Other Working Capital Changes (2019 - 2025)

Historic Other Working Capital Changes for IDEAYA Biosciences (IDYA) over the last 7 years, with Q4 2025 value amounting to $5.6 million.

  • IDEAYA Biosciences' Other Working Capital Changes rose 22356.02% to $5.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $7.8 million, marking a year-over-year increase of 2729.34%. This contributed to the annual value of $7.8 million for FY2025, which is 2729.34% up from last year.
  • Per IDEAYA Biosciences' latest filing, its Other Working Capital Changes stood at $5.6 million for Q4 2025, which was up 22356.02% from -$192000.0 recorded in Q3 2025.
  • In the past 5 years, IDEAYA Biosciences' Other Working Capital Changes ranged from a high of $14.4 million in Q4 2023 and a low of -$26.3 million during Q3 2022
  • In the last 5 years, IDEAYA Biosciences' Other Working Capital Changes had a median value of -$1.7 million in 2021 and averaged -$2.7 million.
  • Per our database at Business Quant, IDEAYA Biosciences' Other Working Capital Changes plummeted by 48205.66% in 2021 and then soared by 47510.45% in 2023.
  • Over the past 5 years, IDEAYA Biosciences' Other Working Capital Changes (Quarter) stood at -$2.0 million in 2021, then tumbled by 96.21% to -$3.8 million in 2022, then surged by 475.1% to $14.4 million in 2023, then plummeted by 88.03% to $1.7 million in 2024, then surged by 223.56% to $5.6 million in 2025.
  • Its last three reported values are $5.6 million in Q4 2025, -$192000.0 for Q3 2025, and $500000.0 during Q2 2025.